case stringlengths 641 3.97k | reasoning stringlengths 324 937 | answer stringlengths 1.44k 6k | category stringclasses 4
values |
|---|---|---|---|
A 9-year-old female presents with a known diagnosis of Juvenile Nasopharyngeal Fibrosarcoma (JNF), confirmed by biopsy and immunohistochemistry (positive for EMA, vimentin, and negative for desmin). Initial staging (6 months ago) was AJCC Stage II, localized to the nasopharynx with minimal sphenoid sinus involvement, n... | JNF Stage II, residual disease post chemo-radiation.
Dural enhancement suggests potential local recurrence/invasion.
Asthma: potential impact on treatment tolerance/recovery.
Hearing loss: baseline deficit, potential for worsening.
Young age: generally better prognosis, but growth potential.
Anxiety: impacts adherence,... | # Prognostic Assessment: Juvenile Nasopharyngeal Fibrosarcoma
This 9-year-old female with JNF presents a complex prognostic scenario due to residual disease, potential dural involvement, and several modifying factors. Prognosis is significantly more challenging than a complete remission post-treatment.
**Short-Term ... | prognostic |
A 48-year-old G3P2 female presents with a known diagnosis of Stage IIIC high-grade serous ovarian cancer, initially diagnosed 18 months ago. She underwent neoadjuvant chemotherapy (6 cycles of carboplatin and paclitaxel) followed by interval debulking surgery (optimal debulking achieved). She then completed 6 cycles of... | Stage IIIC recurrence indicates aggressive disease biology.
BRCA1 mutation suggests PARP inhibitor sensitivity.
TP53 mutations imply chemoresistance potential.
Diabetes complicates treatment, increases infection risk.
Depression impacts adherence, quality of life.
ECOG 2 signifies functional impairment, poor prognosis.... | # Prognostic Assessment: Recurrent Ovarian Cancer
This 48-year-old patient with Stage IIIC high-grade serous ovarian cancer recurrence presents a complex prognostic scenario. Multiple factors contribute to a guarded outlook, but targeted therapies offer potential for improvement.
**Short-Term Prognosis (Days to Weeks... | prognostic |
A 16-year-old Hispanic male with a confirmed diagnosis of severe, uncontrolled asthma (Global Initiative for Asthma - GINA step 5) presents for a routine follow-up. He has experienced frequent exacerbations (average 6 per year) requiring emergency department visits and systemic corticosteroids. He was diagnosed at age ... | Severe asthma, frequent exacerbations indicate poor control.
Obesity worsens asthma, increases inflammation risk.
Recurrent pneumonia suggests immune dysregulation.
Family history of respiratory/mental illness relevant.
Psychosocial factors impact adherence, exacerbations.
Low socioeconomic status, pollution worsen out... | # Prognostic Assessment for Severe Asthma
This 16-year-old male with severe, uncontrolled asthma presents a complex case with multiple high-risk factors, necessitating a detailed prognostic assessment.
**Short-Term Prognosis (Days to Weeks):**
High risk of acute asthma exacerbations requiring emergency department vis... | prognostic |
Mr. Hiroshi Tanaka is an 82-year-old Japanese-American male presenting with worsening dyspnea and cough. He was diagnosed six months ago with Stage IV (T3N2M1) non-small cell lung cancer (NSCLC) – adenocarcinoma with EGFR exon 19 deletion, initially treated with first-line osimertinib. Recent imaging (CT chest/abdomen/... | Progressive disease despite first-line EGFR-TKI treatment.
Stage IV NSCLC inherently carries poor prognosis.
EGFR mutation resistance development is concerning.
Comorbid cardiac disease limits aggressive therapies.
Chronic kidney disease impacts treatment options.
Age 82 increases vulnerability and frailty risk.
APOE4 ... | # Prognostic Assessment for Mr. Hiroshi Tanaka
**Short-Term Prognosis (Days to Weeks):**
Mr. Tanaka is at risk of rapid symptom progression (dyspnea, cough) due to progressive disease. The development of pleural effusions necessitates prompt intervention (thoracentesis) to alleviate symptoms. His short-term prognosis ... | prognostic |
A 72-year-old African American female, Ms. Evelyn Reed, presents with worsening dyspnea on exertion and chronic cough. She was diagnosed with Idiopathic Pulmonary Fibrosis (IPF) 3 years ago, confirmed by HRCT and lung biopsy. Her disease has progressed despite treatment with pirfenidone. Current PFTs show FVC 45% predi... | IPF severity: markedly reduced FVC and DLCO.
Smoking history: contributes to disease progression risk.
Comorbidities: diabetes and hypertension impact prognosis.
MUC5B variant: suggests faster disease course.
6MWT distance: indicates significant functional limitation.
Weight loss: suggests disease acceleration/cachexia... | # Prognostic Assessment for Ms. Evelyn Reed – Idiopathic Pulmonary Fibrosis
**Short-Term Prognosis (Days to Weeks):** Ms. Reed is at risk for acute exacerbation of IPF (AE-IPF) given her progressive dyspnea, weight loss, and declining functional status. The risk of hospitalization for respiratory failure is elevated. ... | prognostic |
Mr. David Chen, a 48-year-old Vietnamese-American male, presents with a confirmed diagnosis of Amyotrophic Lateral Sclerosis (ALS) – specifically, the bulbar-onset form diagnosed 18 months ago. Initial symptom was slurred speech, progressing to dysphagia and fasciculations in the tongue. He currently uses a feeding tub... | Bulbar onset ALS indicates faster disease progression.
ALSFRS-R decline suggests worsening neurological function.
C9orf72 expansion linked to earlier disease onset.
Diabetes may accelerate ALS progression via inflammation.
Hypertension impacts cerebrovascular health, potentially worsening.
Depression reduces adherence ... | # Prognostic Assessment for Mr. David Chen – ALS
**Short-Term Prognosis (Days to Weeks):**
Mr. Chen is at high risk for worsening dysphagia requiring increased suctioning or potential aspiration pneumonia. His declining FVC suggests increasing respiratory insufficiency, potentially necessitating non-invasive ventilati... | prognostic |
A 48-year-old African American female, Ms. Evelyn Reed, presents for follow-up regarding high-grade, non-muscle invasive bladder cancer (HG-NMIBC), pT1G3, diagnosed 6 months ago following hematuria investigation. Initial transurethral resection of bladder tumor (TURBT) showed a single, large, papillary tumor with focal... | High-grade, recurrent CIS indicates aggressive disease biology.
BCG failure suggests poorer overall prognosis and risk.
Diabetes impacts immune function, potentially worsening outcomes.
CKD stage 3a limits systemic therapy options significantly.
Smoking history increases risk of secondary bladder cancers.
BRCA2 VUS add... | # Prognostic Assessment for Ms. Evelyn Reed – High-Grade Non-Muscle Invasive Bladder Cancer
**Short-Term Prognosis (Days to Weeks):**
Ms. Reed faces a high risk of disease progression in the immediate short term. The persistence of CIS despite BCG therapy indicates a treatment failure and a need for prompt escalation ... | prognostic |
A 48-year-old female presents with worsening shortness of breath and productive cough. She was diagnosed 6 months ago with HIV (CD4 count 210/µL at diagnosis, currently 350/µL on antiretroviral therapy - Dolutegravir/Abacavir/Lamivudine), and developed Pneumocystis jirovecii pneumonia (PCP) 3 weeks ago, initially treat... | Recurrent PCP indicates immune reconstitution challenges.
Aspergillus colonization suggests increased fungal susceptibility.
Low CD4 despite ART signals ongoing immune dysfunction.
Diabetes impairs immune response and wound healing.
CKD increases infection risk and treatment toxicity.
Hypoxia and lactate suggest signif... | # Prognostic Assessment: Recurrent PCP with *Aspergillus* Colonization in HIV+
**Short-Term Prognosis (Days to Weeks):**
Guarded. The patient is currently at high risk for acute respiratory failure and secondary bacterial pneumonia. The recurrent PCP despite initial treatment, coupled with *Aspergillus* colonization, ... | prognostic |
A 7-day-old male infant, born at 30 weeks gestation (birth weight 1.2kg), presents with respiratory distress. He was diagnosed with Bronchopulmonary Dysplasia (BPD) – Stage 3 (severe) based on clinical findings and chest radiography. He required mechanical ventilation for the first 5 days of life and is currently on na... | Prematurity significantly increases BPD and PDA risk.
Severe BPD (Stage 3) indicates substantial lung damage.
Hemodynamically significant PDA worsens pulmonary hypertension.
Gestational diabetes links to increased neonatal morbidity.
African American ethnicity: potential genetic predisposition.
Suspected sepsis complic... | # Prognostic Assessment for Infant with Severe BPD, PDA, and PAH
This newborn presents a complex case with multiple interacting factors impacting prognosis. Accurate assessment requires considering the interplay of prematurity, BPD severity, PDA hemodynamics, PAH, potential sepsis, and maternal gestational diabetes, a... | prognostic |
Mr. Arthur Penhaligon is a 72-year-old male admitted to the ICU following a deliberate, massive ingestion of paraquat (diquat dibromide) approximately 36 hours prior to arrival. He presented with initial symptoms of oropharyngeal burning, nausea, vomiting, and abdominal pain. Emergency department evaluation revealed si... | Paraquat ingestion: high dose, delayed presentation, poor prognosis.
Severe respiratory failure necessitates prolonged ventilation.
Renal insufficiency limits drug metabolism, increases toxicity.
Diabetes exacerbates organ damage, impairs healing.
Parkinson’s impacts functional status, recovery potential.
Social isolat... | # Prognostic Assessment for Mr. Arthur Penhaligon
Mr. Penhaligon presents with a severely concerning case of paraquat poisoning complicated by significant comorbidities and psychosocial factors. Prognosis is guarded and requires a multi-faceted assessment.
**Short-Term Prognosis (Days to Weeks):**
His immediate progn... | prognostic |
An 8-year-old male, previously healthy, presents post-motor vehicle collision (MVC). Initial assessment reveals a closed head injury (CHI) with Glasgow Coma Scale (GCS) of 10 (E3, V3, M4) at the scene, improving to 12 (E4, V3, M5) in the ED. CT head shows a small subdural hematoma (SDH) without significant mass effect.... | Initial GCS 12 suggests moderate TBI severity.
SDH presence, even small, increases intracranial pressure risk.
Femur fracture adds systemic stress and pain burden.
Hyponatremia may indicate SIADH post-TBI, worsening edema.
Elevated D-dimer suggests possible coagulopathy/inflammation.
Age 8 generally favors better neuro... | # Prognostic Assessment for 8-Year-Old Male Post-MVC with TBI and Femur Fracture
This case presents a complex scenario requiring careful prognostic assessment due to the interplay of traumatic brain injury (TBI), orthopedic injury, and potential secondary complications. The child’s initial GCS of 10 improving to 12 su... | prognostic |
An 8-year-old female presents with confirmed disseminated Mycobacterium tuberculosis (TB) disease, including miliary TB with pulmonary involvement, tuberculous meningitis (TBM), and vertebral osteomyelitis (L4). She was diagnosed 3 weeks ago and initiated on standard quadruple therapy (isoniazid, rifampicin, pyrazinami... | Disseminated TB, including CNS involvement, signifies high severity.
Malnutrition significantly impairs immune response and treatment efficacy.
TBM predicts neurological sequelae and increased mortality risk.
Vertebral osteomyelitis complicates recovery and mobility.
Inconsistent adherence hinders drug effectiveness an... | # Prognostic Assessment for Disseminated Tuberculosis in an 8-Year-Old Female
This case presents a complex scenario of disseminated TB in a child with multiple high-risk factors, necessitating a detailed prognostic assessment.
**Short-Term Prognosis (Days to Weeks):**
The immediate prognosis is guarded. While the pa... | prognostic |
A 16-year-old African American male with a history of sickle cell disease (HbSS genotype) presents with acute kidney injury (AKI) following a vaso-occlusive crisis requiring multiple transfusions. He was diagnosed with sickle cell disease at birth and has experienced frequent pain crises, requiring regular opioid manag... | Sickle nephropathy: progressive fibrosis, declining renal function.
AKI complicates CKD, accelerating disease progression risk.
HbSS genotype: increased risk of renal failure.
APOL1 risk variants: faster CKD progression observed.
Pulmonary hypertension: worsens overall cardiovascular risk.
Frequent transfusions: iron o... | # Prognostic Assessment for a 16-Year-Old Male with Sickle Cell Nephropathy and AKI
This patient presents a complex case with multiple interacting factors impacting his renal and overall prognosis. His sickle cell disease, compounded by acute kidney injury, chronic kidney disease, pulmonary hypertension, genetic predi... | prognostic |
A 28-year-old female presents with known Takayasu Arteritis (TA) diagnosed 3 years prior based on clinical, laboratory, and imaging findings (PET/CT demonstrating aortic inflammation and stenosis). Initial presentation involved visual disturbances and upper extremity claudication. She was initially treated with high-do... | TA severity: extensive aortic involvement, incomplete remission.
Young age: generally better prognosis, but disease duration matters.
Inflammation persists: indicates ongoing disease activity.
Vascular stenosis: limits perfusion, impacts organ function.
DVT history: increased thrombotic risk, complicates management.
Cl... | # Prognostic Assessment for Takayasu Arteritis
This 28-year-old female with Takayasu Arteritis presents a complex prognostic challenge due to extensive vascular involvement, incomplete remission, and the presence of several modifying factors.
**Short-Term Prognosis (Days to Weeks):**
Relatively stable, but risk of a... | prognostic |
Mr. Elias Vance is a 93-year-old Caucasian male presenting with worsening dyspnea on exertion and lower extremity edema. He has a history of ischemic heart disease (prior MI 10 years ago, status post 2-vessel CABG), chronic kidney disease stage 3b (eGFR 35 mL/min/1.73m²), type 2 diabetes mellitus (HbA1c 7.8%), and atri... | Severe MR significantly impacts cardiac output and prognosis.
LVEF 35% indicates substantial systolic dysfunction.
CKD stage 3b increases cardiovascular risk and mortality.
Atrial fibrillation elevates stroke and heart failure risk.
Advanced age independently worsens outcomes post-intervention.
Reduced functional capac... | # Prognostic Assessment for Mr. Elias Vance
**Short-Term Prognosis (Days to Weeks):**
Mr. Vance is at high risk for near-term decompensation and hospitalization for heart failure. His symptoms are significantly limiting, and the combination of severe mitral regurgitation, reduced LVEF, and renal insufficiency creates ... | prognostic |
A 48-year-old Vietnamese-American female presents with a locally advanced squamous cell carcinoma (SCC) of the nasopharynx, initially diagnosed 6 months ago. She was initially treated with definitive chemoradiation (cisplatin-based) but now demonstrates local recurrence at the posterior nasal cavity and hard palate, co... | Locally recurrent nasopharyngeal SCC indicates aggressive disease.
Smoking history increases recurrence and second malignancy risk.
Diabetes impairs wound healing and treatment tolerance.
Anxiety impacts adherence and quality of life.
Limited social support hinders recovery and coping.
Family history suggests genetic p... | # Prognostic Assessment: Locally Recurrent Nasopharyngeal SCC
This 48-year-old female with recurrent nasopharyngeal SCC presents a complex prognostic challenge due to multiple interacting factors. Her initial Stage III disease, coupled with local recurrence after definitive chemoradiation, significantly worsens her ou... | prognostic |
A 9-year-old female of Ashkenazi Jewish descent presents with a rapidly progressive neurological decline over the past 6 months. Initial presentation included clumsiness and difficulty with fine motor skills. Diagnosis of Late-Onset Tay-Sachs Disease (LOTS) was confirmed via enzyme assay (beta-hexosidase A activity sig... | LOTS severity: Rapid progression, significant motor/cognitive impairment.
Genetic factors: Biallelic *HEXA* mutations, family history impacts.
Age of onset: Later onset generally slower progression.
Respiratory function: Reduced FVC indicates pulmonary involvement.
Comorbidities: Recurrent infections worsen neurologica... | # Prognostic Assessment for Late-Onset Tay-Sachs Disease (LOTS)
This 9-year-old female with LOTS presents a complex prognostic challenge due to the interplay of genetic factors, disease severity, comorbidities, and psychosocial circumstances. Her rapid progression despite being beyond the typical infantile onset sugge... | prognostic |
A 7-day-old male infant, born at 32 weeks gestation (birth weight 1.6kg), presents with worsening abdominal distension, bilious emesis, and failure to pass meconium. His mother is a 28-year-old of Ashkenazi Jewish descent with a known history of cystic fibrosis (CF) carrier status. The father’s CF status is unknown. In... | Prematurity increases respiratory and infectious risks.
Meconium ileus signifies severe CF presentation.
Pseudomonas aeruginosa indicates aggressive infection.
ΔF508/W1282X: severe CFTR mutation combination.
Pancreatic insufficiency worsens nutritional status.
PPHN complicates respiratory management, prognosis.
Family ... | # Prognostic Assessment for Neonatal Cystic Fibrosis with Meconium Ileus and Pseudomonas Infection
This newborn presents a complex case of Cystic Fibrosis (CF) with multiple high-risk factors impacting prognosis. The combination of meconium ileus, *Pseudomonas aeruginosa* infection, prematurity, and a severe CFTR geno... | prognostic |
Mrs. Eleanor Vance is an 82-year-old female with a 15-year history of severe, uncontrolled asthma (Global Initiative for Asthma – GINA step 5). She presents with worsening dyspnea and cough productive of purulent sputum. She was diagnosed with Chronic Obstructive Pulmonary Disease (COPD) – GOLD stage 3 – 5 years ago, s... | Asthma severity: long-standing, uncontrolled, steroid-dependent.
COPD stage 3: significant airflow limitation, reduced quality of life.
HFpEF: contributes to dyspnea, limits exercise tolerance.
MDS: potential for disease progression, cytopenias.
Age 82: increased frailty, reduced physiological reserve.
Comorbidities: m... | # Prognostic Assessment for Mrs. Eleanor Vance
Mrs. Vance presents a complex case with multiple interacting comorbidities, making accurate prognosis challenging. Her prognosis must be considered across short, medium, and long-term horizons.
**Short-Term Prognosis (Days to Weeks):**
Her immediate prognosis is guarded ... | prognostic |
Mr. Arthur Penhaligon is a 72-year-old male admitted after being found wandering outside, disoriented, and exhibiting increasing paranoia. He has a 15-year history of Parkinson’s Disease (Hoehn & Yahr Stage III, fluctuating motor control), well-managed with carbidopa-levodopa. Three months prior to admission, his daugh... | DLB severity: moderate cognitive impairment, visual hallucinations present.
Parkinsonism: Stage III, fluctuating, impacts functional status.
Cardiovascular history: MI, stent, increases overall mortality risk.
Age: 72, increases vulnerability and slower recovery potential.
Vitamin D deficiency: potentially exacerbates ... | # Prognostic Assessment for Mr. Arthur Penhaligon
Mr. Penhaligon presents a complex case of Dementia with Lewy Bodies complicated by Parkinson’s Disease and cardiovascular history, requiring a nuanced prognostic assessment.
**Short-Term Prognosis (Days to Weeks):**
Mr. Penhaligon is at risk for acute neuropsychiatric... | prognostic |
A 9-year-old male of mixed African and European ancestry presents with relapsed B-cell acute lymphoblastic leukemia (B-ALL). He was initially diagnosed 2 years ago and achieved complete remission after standard chemotherapy (ALL-BFM protocol). He relapsed with a blast count of 25% in the bone marrow 6 months ago and re... | Relapsed B-ALL post-allo-HSCT: high-risk situation.
GVHD complicates transplant recovery and prognosis.
MRD positivity indicates persistent disease burden.
*KMT2A* rearrangement: adverse genetic risk factor.
*PH-like* fusion: further worsens prognosis significantly.
Cytopenias suggest graft failure or relapse progressi... | # Prognostic Assessment for Relapsed B-ALL Post-Allo-HSCT
This 9-year-old patient with relapsed B-ALL post-allo-HSCT presents a complex and concerning clinical picture. His prognosis is significantly guarded due to multiple high-risk factors.
**Short-Term Prognosis (Days to Weeks):**
The immediate prognosis is poor.... | prognostic |
A 28-year-old African American female with a 7-year history of Systemic Lupus Erythematosus (SLE) presents with worsening fatigue, lower extremity edema, and dyspnea on exertion. She was initially diagnosed with SLE based on meeting 4/11 ACR criteria (malar rash, serositis, hematologic abnormalities – lymphopenia, and ... | SLE nephritis, Class IV, indicates aggressive disease course.
Renal insufficiency (eGFR 35) signifies significant kidney damage.
High anti-dsDNA suggests active lupus and nephritis flare.
Poor immunosuppression adherence worsens disease control.
Hypertension accelerates renal disease progression risk.
Cardiovascular ri... | # Prognostic Assessment for SLE Nephritis
This 28-year-old African American female with SLE Class IV nephritis presents a complex case with a guarded prognosis. Her disease course is complicated by poor adherence, refractory disease, and significant comorbidities.
**Short-Term Prognosis (Days to Weeks):**
Her immedia... | prognostic |
A 16-year-old Hispanic male, Mateo Rodriguez, presents with relapsed B-cell acute lymphoblastic leukemia (B-ALL). He was initially diagnosed 18 months ago and achieved complete remission after standard induction and consolidation chemotherapy based on the Children’s Oncology Group (COG) protocol. He relapsed with a bla... | Relapsed B-ALL indicates poorer overall survival probability.
High-risk genetics (*TP53*) worsen prognosis significantly.
MRD positivity post-induction predicts relapse risk.
Asthma, obesity, and *UGT1A1* modify treatment tolerance.
ECOG 1 suggests relatively good functional status.
Socioeconomic factors impact adheren... | # Prognostic Assessment for Mateo Rodriguez
## Summary
Mateo is a 16-year-old Hispanic male with relapsed, high-risk B-ALL despite achieving a second remission. Multiple factors contribute to a guarded prognosis, including adverse genetic features, persistent MRD, comorbidities, and socioeconomic challenges.
## Shor... | prognostic |
A 9-year-old female of Ashkenazi Jewish descent presents with a rapidly progressive decline in vision in both eyes over the past 6 months. Initial diagnosis of Stargardt disease (STGD1) was made based on fundus autofluorescence (FAF) showing widespread fleckings and central retinal atrophy. Genetic testing confirmed ho... | STGD1 severity: rapid progression, significant central atrophy.
ABCR mutation: homozygous, predicts more aggressive phenotype.
Age of onset: early onset, worse long-term visual outcome.
Asthma: controlled, minimal direct impact on STGD1 prognosis.
Psychosocial impact: anxiety, withdrawal, hinders adaptation.
Family his... | # Prognostic Assessment for Stargardt Disease (STGD1)
This 9-year-old female with STGD1 presents a challenging prognostic case due to the rapid progression of her disease, compounded by psychosocial factors and a family history of macular degeneration.
**Short-Term Prognosis (Days to Weeks):**
Continued, albeit pote... | prognostic |
A 28-year-old male with a history of Cystic Fibrosis (CF) diagnosed at age 2, presents for pre-operative assessment prior to planned bilateral lung transplantation. He has a compound heterozygous genotype (deltaF508/G551D). His FEV1 is currently 28% predicted, and his DLCO is 22% predicted. He has chronic *Pseudomonas ... | Severe lung disease: FEV1 28%, DLCO 22% predicted.
Chronic multi-drug resistant bacterial colonization present.
CFRD complicates recovery and increases infection risk.
Mild pulmonary hypertension adds cardiac strain.
Malnutrition (BMI 18.5, low pre-albumin) impairs healing.
Psychosocial factors: anxiety, depression, so... | # Prognostic Assessment for Lung Transplant Candidate with Cystic Fibrosis
This 28-year-old male with advanced Cystic Fibrosis presents a high-risk case for lung transplantation, requiring a nuanced prognostic assessment. His prognosis is complex due to interacting factors related to disease severity, comorbidities, a... | prognostic |
Mrs. Eleanor Vance is a 72-year-old Caucasian female with a 15-year history of Type 2 Diabetes Mellitus, poorly controlled (HbA1c consistently 8.5-9.5%). She presented to the emergency department with worsening lower extremity edema and shortness of breath. She was diagnosed with Stage 4 Chronic Kidney Disease (CKD) se... | Stage 4 CKD indicates significant kidney function loss.
Poor diabetes control accelerates CKD progression.
Cardiovascular disease increases mortality risk significantly.
Anemia contributes to fatigue and heart failure risk.
Hyperkalemia poses immediate cardiac arrhythmia threat.
Functional decline predicts poorer outco... | # Prognostic Assessment for Mrs. Eleanor Vance
Mrs. Vance presents a complex case with multiple interacting comorbidities significantly impacting her prognosis. Her advanced CKD, poorly controlled diabetes, and established cardiovascular disease create a high-risk profile.
**Short-Term Prognosis (Days to Weeks):**
He... | prognostic |
Mr. Elias Vance is an 82-year-old Caucasian male with a 15-year history of severe, uncontrolled asthma, currently classified as Step 5 therapy (omalizumab, high-dose inhaled corticosteroids/LABA). He presents with worsening dyspnea and a productive cough for 3 days. He has a history of recurrent *Pseudomonas aeruginosa... | Severe asthma, COPD overlap complicates respiratory assessment.
Recurrent pneumonia indicates impaired immune clearance.
Diabetes impairs immune function, wound healing.
Cardiac history limits aggressive interventions.
Eosinophilia suggests Th2-driven inflammation exacerbation.
Functional dependence impacts recovery po... | # Prognostic Assessment for Mr. Elias Vance
Mr. Vance presents a complex case with multiple interacting conditions significantly impacting his prognosis. His severe asthma, COPD overlap, recurrent pneumonia, diabetes, cardiac history, functional dependence, and genetic predisposition create a high-risk scenario.
**Sh... | prognostic |
A 28-year-old African American female presents with a 3-year history of established systemic lupus erythematosus (SLE). Diagnosis was based on SLICC criteria. Initial presentation included malar rash, serositis (pleuritis), and non-erosive arthritis. Current medications include hydroxychloroquine 200mg daily, mycopheno... | SLE disease activity is currently increasing.
Low complement levels indicate active inflammation.
Anti-dsDNA elevation suggests renal flare risk.
Raynaud’s suggests potential for vascular complications.
Depression impacts adherence and outcomes.
Financial instability worsens disease management.
African American ethnici... | # Prognostic Assessment for Systemic Lupus Erythematosus
This 28-year-old African American female with established SLE presents a complex prognostic challenge due to increasing disease activity, psychosocial stressors, and genetic predisposition.
**Short-Term Prognosis (Days to Weeks):**
There is a high risk of a re... | prognostic |
A 16-year-old African American male presents with a confirmed diagnosis of Stage IIIC epithelial ovarian cancer (serous histology), discovered incidentally during evaluation for acute appendicitis (laparoscopic appendectomy revealed a 10cm complex adnexal mass). Genetic testing revealed a BRCA1 pathogenic variant. He w... | Stage IIIC ovarian cancer indicates advanced disease burden.
BRCA1 mutation suggests chemosensitivity, but recurrence risk.
Male gender assigned at birth complicates treatment response.
Testosterone therapy’s impact on cancer progression is unknown.
Poorly differentiated histology implies aggressive tumor biology.
Posi... | # Prognostic Assessment: Stage IIIC Serous Ovarian Cancer in a Transgender Male Adolescent
This case presents a particularly challenging prognostic scenario due to the confluence of advanced disease, genetic predisposition, gender identity considerations, comorbidities, and psychosocial factors. The patient’s age and ... | prognostic |
A 28-year-old African American male with a history of Sickle Cell Disease (HbSS genotype) presents post-motor vehicle collision. He sustained a traumatic brain injury (TBI) – diffuse axonal injury (DAI), Glasgow Coma Scale (GCS) of 8 initially, now 10 after 48 hours. He also has a closed fracture of the left femur and ... | Severe TBI impacts neurological recovery potential.
SCD increases perioperative and long-term risks.
Splenectomy elevates OPSI risk significantly.
Chronic pain complicates post-op management.
Baseline restrictive lung disease limits reserve.
Frequent VOCs indicate disease severity.
Limited social support hinders rehabi... | # Prognostic Assessment for a 28-Year-Old Male with TBI, SCD, and Splenectomy
This patient presents a complex case with multiple interacting factors significantly impacting his prognosis. His prognosis must be considered across short, medium, and long-term horizons.
**Short-Term Prognosis (Days to Weeks):**
The imme... | prognostic |
A 16-year-old female, Sarah, presents with a confirmed diagnosis of Cystic Fibrosis (CF) – DeltaF508 homozygous mutation. She was diagnosed at age 6 following recurrent pneumonia. Current FEV1 is 55% predicted. She experiences frequent pulmonary exacerbations (average 3 per year requiring IV antibiotics). She has CF-re... | CFTR mutation type: DeltaF508 predicts more severe disease.
FEV1 55% indicates moderate lung function impairment.
Frequent exacerbations signify ongoing inflammatory burden.
CFRD complicates prognosis, increasing mortality risk.
Chronic *B. dolosa* infection worsens lung damage.
Mucoid conversion suggests treatment fai... | # Prognostic Assessment for Sarah – Cystic Fibrosis
**Short-Term Prognosis (Days to Weeks):**
Sarah is at high risk for another pulmonary exacerbation requiring hospitalization within the next few weeks, given her recent hospitalization, increasing dyspnea, and persistent *B. dolosa* infection. Her current clinical st... | prognostic |
Mr. Elias Vance is a 72-year-old African American male admitted to the ICU with severe pneumonia secondary to multi-drug resistant *Pseudomonas aeruginosa*. He was initially treated as an outpatient with oral antibiotics for 3 days, but symptoms worsened, leading to hospitalization. He has a history of COPD (GOLD Stage... | Severe pneumonia, MDR *Pseudomonas*, high SOFA score.
Age >65 increases mortality risk significantly.
COPD exacerbation worsens respiratory compromise.
Diabetes impairs immune function, delays healing.
CKD increases susceptibility to infection, limits treatment.
Prior MI suggests cardiovascular vulnerability.
Limited s... | # Prognostic Assessment for Mr. Elias Vance
Mr. Vance presents with a very high-risk profile for adverse outcomes following severe pneumonia due to multi-drug resistant *Pseudomonas aeruginosa*. His advanced age, significant comorbidities, and the severity of his illness necessitate a cautious and realistic prognosis.... | prognostic |
A 52-year-old female presents to the ED with worsening shortness of breath and productive cough. She was diagnosed with Stage IV (T3N2M1) HER2-negative, hormone receptor-positive metastatic breast cancer 3 years ago, initially responding well to letrozole. However, she experienced disease progression 6 months ago, swit... | Metastatic cancer stage IV indicates poor overall prognosis.
Pulmonary metastases worsen respiratory compromise, impacting survival.
Pleural effusion causes dyspnea, reducing functional capacity.
ECOG 2 signifies moderate functional impairment, affecting outcomes.
Prior treatment failure limits further therapeutic opti... | # Prognostic Assessment for Metastatic Breast Cancer
This 52-year-old female with Stage IV HER2-negative, hormone receptor-positive breast cancer presents a complex prognostic challenge due to multiple interacting factors. Her disease has progressed despite second-line therapy, and she exhibits significant symptom bur... | prognostic |
A 7-day-old male infant, born at 32 weeks gestation (birth weight 1.6kg), presents with bilateral hydronephrosis detected on routine neonatal ultrasound. Subsequent voiding cystourethrogram (VCUG) confirms bilateral vesicoureteral reflux (VUR), graded IV on the right and III on the left. Renal ultrasound reveals cortic... | Prematurity increases VUR severity and complications risk.
High-grade bilateral VUR indicates significant renal damage potential.
Early-life UTI exacerbates renal scarring and functional loss.
ARPKD family history suggests genetic predisposition to kidney disease.
Cortical scarring signifies irreversible renal parenchy... | # Prognostic Assessment for Bilateral High-Grade VUR in a Neonate
This 7-day-old infant with bilateral high-grade VUR, complicated by prematurity, early-life UTI, cortical scarring, and a family history of ARPKD, presents a complex prognostic challenge. The presence of both IV and III grade VUR, coupled with existing... | prognostic |
Mr. Arthur Penhaligon is a 72-year-old male with a history of well-controlled type 2 diabetes mellitus, hypertension, and chronic kidney disease stage 3a (eGFR 48 ml/min/1.73m2). He presents with a rapidly enlarging nodular melanoma (Breslow thickness 3.2mm, Clark level IV, mitotic rate 12/mm2, ulceration present) on h... | Melanoma stage III, high-risk features present.
Positive lymph nodes indicate increased recurrence risk.
Breslow thickness impacts survival significantly.
Extracapsular extension worsens prognosis considerably.
BRAF V600E mutation offers targeted therapy options.
CKD stage 3a complicates systemic therapy tolerance.
ECO... | # Prognostic Assessment for Mr. Arthur Penhaligon
**Short-Term Prognosis (Days to Weeks):**
Mr. Penhaligon is at moderate risk of wound complications (infection, dehiscence) due to his age, chronic kidney disease, and leg edema. Pain management will be crucial. He will require ongoing monitoring for lymphedema and pot... | prognostic |
Mr. Arthur Penhaligon is a 72-year-old male with a history of Stage IV Non-Small Cell Lung Cancer (NSCLC) – adenocarcinoma, initially diagnosed 18 months ago. He initially responded to first-line platinum-based chemotherapy (cisplatin/pemetrexed) achieving a partial response for 9 months. He progressed on therapy 6 mon... | Stage IV NSCLC indicates poor overall prognosis.
Prior chemotherapy failure signals acquired resistance.
Brain metastases worsen prognosis significantly.
ECOG 2 suggests moderate functional impairment.
Smoking history increases risk of further complications.
Elevated LDH correlates with tumor burden/prognosis.
Comorbid... | # Prognostic Assessment for Mr. Arthur Penhaligon
Mr. Penhaligon presents a complex case of advanced NSCLC with multiple high-risk features, necessitating a nuanced prognostic assessment.
**Short-Term Prognosis (Days to Weeks):**
His immediate prognosis is guarded. The worsening dyspnea and chest pain from pleural ef... | prognostic |
An 8-year-old Navajo male presents with a confirmed diagnosis of Stage III Juvenile Nasopharyngeal Rhabdomyosarcoma (JNRM), embryonal subtype. He initially presented with unilateral nasal obstruction and epistaxis 6 weeks ago. Biopsy revealed the diagnosis. Imaging (MRI and CT) demonstrates extension into the posterior... | Stage III JNRM indicates aggressive disease potential.
Residual cavernous sinus disease post-chemo is concerning.
Embryonal subtype generally has better prognosis.
Mild asthma, well-controlled, minimal prognostic impact.
Navajo ethnicity: potential genetic predisposition, access issues.
TP53 variant: uncertain signific... | # Prognostic Assessment: Juvenile Nasopharyngeal Rhabdomyosarcoma
This 8-year-old Navajo male with Stage III embryonal JNRM presents a complex prognostic scenario. The presence of residual disease after initial chemotherapy, coupled with social and genetic factors, significantly influences his outlook.
**Short-Term P... | prognostic |
A 6-month-old female infant of Ashkenazi Jewish descent presents with a history of recurrent severe infections since 3 months of age. Initial evaluation revealed eczema, recurrent staphylococcal skin abscesses, and pneumonia requiring hospitalization. Genetic testing confirmed a diagnosis of X-linked Agammaglobulinemia... | XLA severity: complete B cell absence, high infection risk.
IVIG non-response: suggests inadequate antibody protection.
Recurrent *Pseudomonas* pneumonia: chronic lung damage risk.
Aspergillus co-infection: increased morbidity and mortality.
Developmental delay: impacts long-term neurodevelopment.
Family IBD history: p... | # Prognostic Assessment for X-Linked Agammaglobulinemia (XLA)
This 6-month-old female with XLA presents a complex case with multiple high-risk factors impacting her prognosis. Her complete B cell deficiency, coupled with poor response to IVIG and recurrent, severe infections, significantly worsens her outlook.
**Shor... | prognostic |
Mr. David Chen is a 28-year-old male diagnosed 3 years ago with Ankylosing Spondylitis (AS) based on modified New York criteria, confirmed by positive HLA-B27 and sacroiliitis on MRI. He initially responded well to NSAIDs and physical therapy. However, over the past year, his disease has progressed despite maximal tole... | AS severity: progressive disease despite conventional treatment.
Uveitis frequency: indicates aggressive disease phenotype.
Crohn’s disease: increases systemic inflammatory burden.
Smoking: worsens AS progression and uveitis risk.
High CRP/ESR: reflects ongoing inflammation.
Restricted lung function: potential for futu... | # Prognostic Assessment for Mr. David Chen
**Short-Term Prognosis (Days to Weeks):**
Mr. Chen is at high risk for continued pain exacerbations and further functional decline if current treatment remains unchanged. He is also at risk for recurrent uveitis episodes, potentially leading to vision loss if not promptly man... | prognostic |
Mr. David Miller is a 52-year-old male presenting for follow-up regarding neovascular age-related macular degeneration (nAMD) in his right eye. He was diagnosed 18 months ago and initially responded well to intravitreal aflibercept injections (every month for 6 months, then every other month). However, over the past 3 ... | AMD severity: advanced, persistent fluid despite treatment.
Diabetes: poor control worsens vascular fragility.
Hypertension: contributes to retinal vascular damage.
Smoking: significant, ongoing risk factor for progression.
Anxiety/depression: impacts adherence and quality of life.
Functional decline: limits adaptation... | # Prognostic Assessment for Mr. David Miller – Neovascular AMD
**Short-Term Prognosis (Days to Weeks):**
Mr. Miller is at high risk for further visual acuity decline in the right eye despite continued aflibercept treatment. The persistent subretinal and intraretinal fluid, coupled with his poor systemic control and on... | prognostic |
Mr. Arthur Penhaligon is an 82-year-old male with a 15-year history of Type 2 Diabetes Mellitus, poorly controlled (HbA1c consistently >8.5%). He presented 3 months ago with progressive fatigue, weight loss (8kg in 6 months), and new-onset lower extremity edema. Initial workup revealed a significantly elevated serum cr... | Diabetes duration and control significantly impact kidney disease progression.
CKD stage 3b indicates substantial renal function impairment.
Cardiovascular disease increases mortality risk in CKD patients.
Hyperparathyroidism exacerbates bone disease and cardiovascular risk.
Age >80 years worsens prognosis across multi... | # Prognostic Assessment for Mr. Arthur Penhaligon
**Short-Term Prognosis (Days to Weeks):**
Mr. Penhaligon is at moderate risk of acute kidney injury exacerbation due to ongoing diabetic nephropathy and potential medication side effects (ACE inhibitor). He is also at risk for cardiovascular events, though currently st... | prognostic |
Eight-year-old female, Maya, presents with a confirmed diagnosis of Severe, Treatment-Resistant Major Depressive Disorder (TR-MDD) with mixed features and significant suicidal ideation (though no prior attempts). Diagnosis established 6 months ago following comprehensive evaluation including Kiddie-SADS-PL. Maya’s moth... | TR-MDD severity: high, multiple failed treatments indicate poor response.
Family history: maternal depression, paternal SUD – increased vulnerability.
Bullying trauma: significant stressor, exacerbates depressive symptoms.
ADHD comorbidity: complicates treatment, impacts functional outcomes.
Poor treatment response: su... | # Prognostic Assessment for Maya
**Short-Term Prognosis (Days to Weeks):**
Maya is at *high risk* for continued suicidal ideation and potential escalation. Hospitalization may be required for safety stabilization. Expect limited immediate improvement with current treatment given treatment resistance. Focus will be on ... | prognostic |
An 8-year-old female presents with a 6-month history of recurrent acute arthritis affecting multiple large and small joints, accompanied by daily spiking fevers. Initial evaluation revealed negative ANA, RF, and anti-CCP. However, after 3 months, a positive ANA (1:640, speckled pattern) emerged, alongside elevated infl... | Systemic JIA severity: active disease, organ involvement present.
Macrophage activation syndrome (MAS) risk is significantly elevated.
Comorbid asthma: potential for increased infection susceptibility.
Family history SLE: genetic predisposition to autoimmunity.
Methotrexate partial response: treatment refractoriness co... | # Prognostic Assessment for Systemic JIA with Comorbidities
This 8-year-old patient with systemic JIA presents a complex prognostic challenge due to active disease, organ involvement, comorbidities, and social factors. Her case is concerning for potential macrophage activation syndrome (MAS), a life-threatening compli... | prognostic |
Mr. Arthur Penhaligon is a 72-year-old male admitted for worsening shortness of breath. He has a history of Stage III Chronic Obstructive Pulmonary Disease (GOLD classification) with frequent exacerbations, ischemic heart disease (post-MI 5 years ago, 2 stents), poorly controlled Type 2 Diabetes Mellitus (HbA1c 8.2%), ... | COPD stage III, frequent exacerbations, indicates significant disease.
Ischemic heart disease post-MI increases cardiovascular risk.
Diabetes poorly controlled worsens multiple organ dysfunction.
CKD stage 3a limits treatment options, impacts mortality.
Untreated depression negatively impacts adherence, recovery.
Funct... | # Prognostic Assessment for Mr. Arthur Penhaligon
**Short-Term Prognosis (Days to Weeks):**
Mr. Penhaligon faces a guarded short-term prognosis. His current admission for acute respiratory distress secondary to COPD exacerbation complicated by heart failure carries a significant risk of in-hospital mortality (estimate... | prognostic |
Mr. Arthur Penhaligon is a 68-year-old male presenting with newly diagnosed Stage IV Non-Small Cell Lung Cancer (NSCLC) with adenocarcinoma histology. He was a heavy smoker (60 pack-years) who quit 5 years ago. Initial imaging reveals a 7cm primary tumor in the right upper lobe with mediastinal lymph node involvement a... | Stage IV NSCLC indicates inherently poor prognosis.
Smoking history significantly increases risk of recurrence.
EGFR mutation suggests targeted therapy responsiveness.
Comorbidities (CKD, CAD) limit treatment options.
Weight loss indicates advanced disease and poor reserve.
ECOG 2 reflects reduced functional capacity.
... | # Prognostic Assessment for Mr. Arthur Penhaligon
**Short-Term Prognosis (Days to Weeks):**
Mr. Penhaligon’s short-term prognosis is guarded. He is likely to experience continued symptom burden (dyspnea, fatigue) and potential complications related to his comorbidities. Initiation of targeted therapy (EGFR TKI) is cru... | prognostic |
Mr. Arthur Penhaligon is a 72-year-old male presenting with a confirmed diagnosis of Stage IIIC high-grade serous ovarian cancer (HGSOC) following a recent exploratory laparotomy and biopsy. He was initially misdiagnosed with benign prostatic hypertrophy and presented with increasing abdominal distension, early satiety... | Stage IIIC HGSOC indicates advanced disease burden.
Age 72 increases risk of chemotherapy toxicity.
CKD impacts chemotherapy metabolism and tolerance.
Prior MI suggests cardiovascular reserve limitations.
ECOG 2 signifies moderate functional impairment.
Negative BRCA status limits PARP inhibitor options.
CA-125 decline... | # Prognostic Assessment for Mr. Arthur Penhaligon
Mr. Penhaligon presents a complex case of advanced HGSOC with multiple comorbidities impacting prognosis. His age, stage of disease, functional status, and pre-existing conditions all contribute to a guarded outlook.
**Short-Term Prognosis (Days to Weeks):**
Mr. Penha... | prognostic |
A 28-year-old male presents with a confirmed diagnosis of Stage IIIC (T3N2M0) non-small cell lung cancer (NSCLC), adenocarcinoma histology, EGFR wild-type, PD-L1 50% expression. He was diagnosed after presenting with persistent cough and hemoptysis. He has a 40 pack-year smoking history, having started at age 16. He al... | Stage IIIC NSCLC indicates aggressive disease potential.
Smoking history significantly worsens prognosis.
Adenocarcinoma histology impacts treatment options.
PD-L1 50% suggests immunotherapy benefit potential.
Crohn’s/azathioprine increases infection risk, delays treatment.
ECOG 1 indicates moderate functional capacity... | # Prognostic Assessment for Stage IIIC NSCLC
This 28-year-old male with Stage IIIC NSCLC presents a complex prognostic scenario due to interacting factors. His relatively young age is a *potential* positive factor, but is significantly offset by his heavy smoking history, advanced stage, and comorbidities.
**Short-Te... | prognostic |
A 48-year-old African American female with a 10-year history of Systemic Lupus Erythematosus (SLE) presents with worsening fatigue, dyspnea on exertion, and new-onset lower extremity edema. Her SLE has historically been managed with mycophenolate mofetil and low-dose prednisone (5mg daily). Recent labs reveal a creatin... | SLE disease activity significantly elevated, impacting multiple organs.
Renal involvement: proteinuria, rising creatinine, lupus nephritis.
Hypertension poorly controlled, accelerating renal damage.
Anemia contributes to fatigue, reduced functional status.
APOL1 risk variant increases risk of progressive kidney disease... | # Prognostic Assessment for SLE with Lupus Nephritis
This 48-year-old African American female with SLE and lupus nephritis presents a complex case with a guarded prognosis. Her disease activity is high, with significant renal involvement, uncontrolled hypertension, and psychosocial stressors. The presence of the *APOL... | prognostic |
Ethan Miller is an 8-year-old male with a confirmed diagnosis of Duchenne Muscular Dystrophy (DMD) diagnosed at age 6. Genetic testing revealed a frameshift mutation in the dystrophin gene. He currently presents with Gowers’ sign, calf pseudohypertrophy, and mild scoliosis. His 6-minute walk test (6MWT) distance is 350... | DMD severity: Genetic mutation predicts rapid progression.
Age of onset: Earlier onset correlates with worse outcomes.
6MWT decline: Indicates worsening muscle function quickly.
Cardiac involvement: Early dysfunction impacts long-term survival.
Pulmonary function: Reduced FVC signals respiratory decline.
Glucocorticoid... | # Prognostic Assessment for Ethan Miller - Duchenne Muscular Dystrophy
**Short-Term Prognosis (Days to Weeks):**
Ethan is currently stable on prednisone, but ongoing monitoring for side effects (weight gain, glucose intolerance, behavioral changes) is crucial. Expect continued, albeit potentially slowed, decline in 6M... | prognostic |
Mr. David Chen is a 28-year-old male who presents with a confirmed diagnosis of Stage IIIC, Grade 3, serous ovarian cancer. He was initially misdiagnosed with testicular torsion due to a large, painful scrotal mass, which was ultimately found to be a metastatic deposit from the primary ovarian tumor. Genetic testing re... | Stage IIIC ovarian cancer indicates advanced disease burden.
Grade 3 histology signifies aggressive tumor biology.
BRCA1 mutation suggests potential PARP inhibitor benefit.
Diabetes complicates recovery and increases infection risk.
Diabetic nephropathy limits chemotherapy options/tolerance.
Untreated depression impact... | # Prognostic Assessment for Mr. David Chen
Mr. Chen presents a complex case of advanced ovarian cancer with multiple high-risk factors impacting prognosis. His case is particularly challenging due to the unusual presentation, underlying comorbidities, and suboptimal response to initial treatment.
**Short-Term Prognos... | prognostic |
Ms. Eleanor Vance is a 52-year-old female presenting with worsening dyspnea and fatigue. She was diagnosed 3 years ago with Stage III invasive ductal carcinoma (ER+, PR+, HER2-) of the right breast, initially treated with neoadjuvant chemotherapy (doxorubicin/cyclophosphamide followed by paclitaxel), lumpectomy, and ra... | Metastatic breast cancer, poor response to first-line therapy.
Visceral crisis (lung mets) impacts short-term survival.
Bone metastases suggest aggressive disease biology.
Comorbid CKD limits treatment options, increases toxicity.
ECOG 1 indicates declining functional reserve.
Psychosocial distress worsens outcomes, tr... | # Prognostic Assessment for Ms. Eleanor Vance
Ms. Vance presents a complex case of metastatic breast cancer with multiple interacting factors influencing her prognosis. Her disease has progressed despite first-line endocrine therapy combined with CDK4/6 inhibition, indicating a less favorable response. The presence of... | prognostic |
Mr. David Chen is a 28-year-old male who was diagnosed with IgA nephropathy 5 years ago following a microscopic hematuria workup after a URI. He initially presented with mild proteinuria (1.2g/day) and normal renal function. Over the past year, proteinuria has steadily increased to 3.5g/day. Recent renal biopsy showed ... | IgA nephropathy, crescentic form, indicates aggressive disease.
Proteinuria 3.5g/day signifies substantial glomerular damage.
eGFR 48, declining 5ml/min/year, indicates progressive loss.
Hypertension poorly controlled, accelerates renal decline.
Interstitial fibrosis/tubular atrophy: irreversible damage present.
Depres... | # Prognostic Assessment for Mr. David Chen – IgA Nephropathy
**Short-Term Prognosis (Days to Weeks):**
Mr. Chen is at risk for worsening edema, fatigue, and potentially acute kidney injury (AKI) if blood pressure remains uncontrolled and proteinuria is not addressed. He may require diuretic therapy for symptom managem... | prognostic |
Mrs. Evelyn Reed is an 82-year-old African American female with a history of longstanding Type 2 Diabetes Mellitus (diagnosed 25 years ago, poorly controlled, HbA1c 9.2%), Hypertension (managed with three medications), Hyperlipidemia, and Chronic Kidney Disease (CKD Stage 3b, eGFR 38 mL/min/1.73m2). She presents with a... | Acute limb ischemia severity dictates immediate risk.
CKD stage 3b increases perioperative and long-term risk.
Diabetes complicates wound healing and amputation risk.
Prior MI suggests underlying cardiovascular disease burden.
Poor glycemic control worsens micro/macrovascular outcomes.
Limited social support impacts po... | # Prognostic Assessment for Mrs. Evelyn Reed
**Short-Term Prognosis (Days to Weeks):**
Mrs. Reed faces a high immediate risk of limb loss (amputation) and systemic complications. The acute limb ischemia, if not rapidly addressed with revascularization, will likely lead to irreversible muscle and nerve damage. The ele... | prognostic |
A 9-year-old female presents with relapsed Acute Lymphoblastic Leukemia (ALL), Philadelphia chromosome positive (Ph+). Initial diagnosis was B-cell ALL at age 6, achieving remission after standard chemotherapy. She relapsed 18 months later with central nervous system (CNS) involvement confirmed by MRI and CSF cytology.... | Ph+ ALL relapse indicates higher risk of treatment failure.
CNS involvement worsens prognosis significantly.
MRD positivity suggests incomplete remission.
TKI response crucial, but resistance possible.
Asthma complicates supportive care, infection risk.
Developmental delay impacts quality of life assessment.
Karnofsky ... | # Prognostic Assessment for Relapsed Ph+ ALL
This 9-year-old patient with relapsed Ph+ ALL presents a complex prognostic scenario. Several factors contribute to a guarded outlook, but potential for improvement exists with continued aggressive management.
**Short-Term Prognosis (Days to Weeks):**
Her immediate prognos... | prognostic |
8-year-old female, Maya, presents with Stage III Anaplastic Large Cell Lymphoma (ALCL), ALK-positive. Diagnosis confirmed via biopsy and PET/CT scan showing involvement of mediastinal lymph nodes and limited bone marrow involvement (5% blasts). She completed 6 cycles of chemotherapy (Doxorubicin, Vincristine, Crizotini... | ALCL stage III, ALK-positive: intermediate risk group.
Partial response post-chemotherapy: incomplete disease eradication.
Cardiac dysfunction: increases perioperative and long-term risk.
Cerebral palsy: impacts functional reserve and recovery.
Asthma: potential for respiratory complications during treatment.
Psychosoc... | # Prognostic Assessment for Maya – Stage III ALK+ ALCL
**Short-Term Prognosis (Days to Weeks):**
Maya faces a moderate risk of complications related to ongoing cytopenias, primarily neutropenic fever and bleeding. The mild left ventricular dysfunction necessitates careful monitoring during any further chemotherapy or ... | prognostic |
A 48-year-old G2P1 female presents with a known diagnosis of Stage IIIC high-grade serous ovarian cancer, initially diagnosed 18 months ago. She underwent neoadjuvant chemotherapy (6 cycles of carboplatin and paclitaxel) followed by interval debulking surgery. Pathology post-surgery revealed residual disease (approxima... | Stage IIIC recurrence indicates aggressive disease biology.
Short platinum-free interval suggests chemoresistance.
Elevated CA-125 confirms active disease progression.
Peritoneal carcinomatosis limits surgical options.
Diabetes and CKD complicate treatment tolerance.
ECOG 1 indicates moderate functional impairment.
Lim... | # Prognostic Assessment: Recurrent Ovarian Cancer
This 48-year-old patient with Stage IIIC high-grade serous ovarian cancer recurrence presents a challenging prognostic scenario. Her disease demonstrates aggressive characteristics, and several factors contribute to a guarded prognosis.
**Short-Term Prognosis (Days to... | prognostic |
Mr. David Miller is a 52-year-old male with a history of poorly controlled Type 2 Diabetes Mellitus (diagnosed 15 years ago, HbA1c consistently >8.5%), hypertension (diagnosed 10 years ago, currently on lisinopril 20mg daily), hyperlipidemia (diagnosed 8 years ago, on atorvastatin 40mg daily), and a 25 pack-year smokin... | Acute limb ischemia: severe, threatens limb viability.
Diabetes: accelerates atherosclerosis, impairs healing.
CKD: increases cardiovascular risk, limits interventions.
Smoking: significant contributor to vascular disease.
TASC II C lesion: complex, challenging revascularization.
Distal embolization: worsens ischemia, ... | # Prognostic Assessment for Mr. David Miller
**Short-Term Prognosis (Days to Weeks):**
Mr. Miller faces a high risk of limb loss within the next few days to weeks if definitive revascularization is not achieved. The acute limb ischemia, coupled with his significant comorbidities, creates a critical situation. The elev... | prognostic |
Mrs. Evelyn Reed is a 72-year-old African American female with a history of Stage IV (T3N2M1) HER2-positive metastatic breast cancer diagnosed 3 years ago. She initially responded well to trastuzumab and chemotherapy, achieving a partial remission lasting 18 months. However, she has now experienced progressive disease ... | Metastatic breast cancer, stage IV, poor prognosis.
HER2-positive status impacts treatment response.
BRCA1 mutation suggests potential PARP inhibitor benefit.
ECOG 2 indicates moderate functional impairment.
Poorly controlled diabetes worsens overall health.
Multiple metastases signify advanced disease burden.
Rising C... | # Prognostic Assessment for Mrs. Evelyn Reed
Mrs. Reed presents a complex case of metastatic breast cancer with multiple factors influencing her prognosis. Her advanced stage (IV), HER2-positive status, and BRCA1 mutation all contribute to the overall assessment. However, her comorbidities, functional status, and psyc... | prognostic |
Ms. Anya Sharma, a 48-year-old postmenopausal South Asian woman, presents with a history of Stage IIIC, Grade 3 serous ovarian cancer diagnosed 6 months ago. She initially underwent neoadjuvant chemotherapy (paclitaxel and carboplatin) followed by interval debulking surgery. Pathology revealed residual disease (approxi... | Stage IIIC, Grade 3 indicates aggressive disease biology.
BRCA1 mutation worsens prognosis, chemo sensitivity variable.
Residual disease post-debulking signifies incomplete resection.
Rising CA-125 suggests disease recurrence possibility.
Lung nodule raises concern for distant metastasis.
Diabetes and hypertension impa... | # Prognostic Assessment for Ms. Anya Sharma
Ms. Sharma presents a complex case of recurrent ovarian cancer with multiple factors influencing her prognosis. Her initial diagnosis of Stage IIIC, Grade 3 serous ovarian cancer, coupled with a BRCA1 mutation, indicates a particularly aggressive disease course. While she in... | prognostic |
A 2.5-year-old female of African American descent presents with a known diagnosis of Focal Segmental Glomerulosclerosis (FSGS), confirmed by kidney biopsy 6 months prior. Initial presentation involved nephrotic syndrome (proteinuria 4.8g/g creatinine, hypoalbuminemia 2.2g/dL, edema). She initially responded partially t... | FSGS severity: Persistent nephrotic syndrome, declining eGFR.
African American ethnicity: Higher risk of FSGS progression.
Cyclosporine resistance: Indicates aggressive disease course.
Hypertension: Accelerates kidney damage, poor prognosticator.
NPHS1 variant: Potential for genetic disease progression.
Recurrent infec... | # Prognostic Assessment for FSGS in a 2.5-Year-Old Female
**Short-Term Prognosis (Days to Weeks):**
The patient is at moderate risk of acute kidney injury (AKI) due to ongoing nephrotic syndrome, hypertension, and potential medication side effects (cyclosporine toxicity). Expect continued proteinuria and edema. Risk ... | prognostic |
Mr. Arthur Penhaligon is a 72-year-old male admitted to the ICU following intentional ingestion of paraquat (diquat dibromide) approximately 36 hours prior to arrival. He presented with initial symptoms of oral burning, dysphagia, and abdominal pain. His past medical history includes well-controlled type 2 diabetes mel... | Paraquat ingestion: severity correlates with concentration, time elapsed.
Initial paraquat level suggests significant potential for toxicity.
Acute kidney injury complicates elimination, worsens prognosis.
Pre-existing cardiac disease increases vulnerability to complications.
Pulmonary involvement indicates progressive... | # Prognostic Assessment for Paraquat Toxicity in Mr. Penhaligon
**Short-Term Prognosis (Days to Weeks):**
Mr. Penhaligon’s short-term prognosis is *grave*. He is currently critically ill, requiring vasopressor support and experiencing progressive respiratory failure despite supplemental oxygen. The combination of para... | prognostic |
A 16-year-old female, Sarah, presents with a 6-month history of worsening Crohn’s disease, initially diagnosed via colonoscopy and biopsy showing transmural inflammation, non-caseating granulomas, and ileal involvement. She was initially managed with budesonide with partial response. Current symptoms include persistent... | Crohn’s disease: active, severe, extensive small bowel involvement.
Young age at diagnosis: suggests aggressive disease course.
Low albumin: indicates significant inflammation and malnutrition.
Elevated CRP/ESR: reflects ongoing inflammatory process.
Stricturing: potential for future complications, surgery.
Family hist... | # Prognostic Assessment for Sarah – Crohn’s Disease
**Short-Term Prognosis (Days to Weeks):**
Sarah is at high risk for near-term complications. Her active inflammation, malnutrition (low albumin, BMI), and ongoing symptoms (severe pain, diarrhea) suggest a high likelihood of continued symptom burden and potential for... | prognostic |
A 16-year-old male, previously healthy, presents with progressive weakness and sensory changes over the past 6 months. Initial workup revealed a diagnosis of Multiple Sclerosis (MS), specifically relapsing-remitting MS (RRMS), confirmed by MRI showing disseminated demyelinating lesions in the brain and spinal cord. He ... | RRMS diagnosis confirmed; early disease course established.
Multiple relapses indicate aggressive disease phenotype.
New MRI lesions suggest ongoing inflammatory activity.
Early age of onset correlates with poorer long-term outcomes.
Comorbid anxiety/depression impacts functional recovery.
Family history suggests genet... | # Prognostic Assessment for a 16-Year-Old Male with RRMS
This case presents a complex scenario requiring careful prognostic assessment due to the interplay of multiple factors. The patient’s young age at diagnosis, aggressive disease course, and presence of comorbidities significantly influence his expected trajectory... | prognostic |
A 48-year-old female presents with a 3-year history of progressive Multiple Sclerosis (MS), initially relapsing-remitting (RRMS), now secondary progressive (SPMS). She was diagnosed based on clinical presentation, MRI showing disseminated demyelination, and CSF oligoclonal bands. Current EDSS score is 6.5, indicating s... | SPMS stage indicates worsening neurological disability.
EDSS 6.5 signifies substantial functional impairment.
Active lesions suggest ongoing inflammatory activity.
Brain atrophy correlates with irreversible damage.
Smoking history increases MS progression risk.
Family history indicates genetic predisposition.
Vitamin D... | # Prognostic Assessment for Secondary Progressive Multiple Sclerosis
This 48-year-old female with SPMS presents a complex prognostic challenge due to multiple interacting factors. Her established SPMS, coupled with ongoing disease activity and significant disability, necessitates a detailed assessment.
**Short-Term P... | prognostic |
An 8-year-old male, Leo, presents with a confirmed diagnosis of Stage IV Retinoblastoma in his left eye. The tumor is large (diameter >10mm) and involves the macula, with evidence of choroidal invasion and vitreous seeding on MRI. Genetic testing revealed a non-heritable RB1 mutation. Leo has a history of moderate deve... | Stage IV retinoblastoma indicates aggressive disease course.
Large tumor size worsens prognosis significantly.
Macular involvement threatens central vision loss.
Choroidal invasion increases metastatic risk.
Vitreous seeding suggests further disease spread.
Developmental delay impacts functional recovery.
Limited socia... | # Prognostic Assessment for Leo - Stage IV Retinoblastoma
**Short-Term Prognosis (Days to Weeks):**
Leo’s short-term prognosis is guarded, primarily focused on completing neoadjuvant chemotherapy and preparing for enucleation. The immediate risks include chemotherapy-related side effects (myelosuppression, neuropathy)... | prognostic |
Mrs. Eleanor Vance is an 82-year-old female admitted to the hospital with community-acquired pneumonia (CAP) secondary to *Streptococcus pneumoniae*, serotype 3. She lives alone in a rural area with limited social support. Her past medical history includes chronic obstructive pulmonary disease (COPD) – GOLD Stage 3, po... | Pneumonia severity: CURB-65 score indicates moderate risk.
COPD exacerbation complicates respiratory function significantly.
Diabetes impairs immune response, delaying recovery.
CKD increases susceptibility to complications, poor drug clearance.
IHD increases risk of cardiac events during illness.
Age >80 associated wi... | # Prognostic Assessment for Mrs. Eleanor Vance
**Short-Term Prognosis (Days to Weeks):**
Mrs. Vance faces a guarded short-term prognosis. Despite appropriate antibiotic therapy, her CURB-65 score of 3 indicates a significant risk of mortality (estimated 15-30% within 30 days, though this is a population average). Her ... | prognostic |
A 72-year-old Vietnamese woman, Mrs. Nguyen, presents with locally advanced squamous cell carcinoma (SCC) of the oral tongue (Stage IV, pT4N2bM0). She was diagnosed 3 months ago after noticing a non-healing ulcer. Initial biopsy confirmed SCC. She completed neoadjuvant chemotherapy (cisplatin/5-FU) and radiation therap... | Stage IV SCC, residual disease post-treatment indicates poor prognosis.
Advanced age (72) increases risk of treatment complications.
Comorbidities (diabetes, HTN, CKD) worsen overall health status.
TP53 variant suggests reduced chemotherapy response potential.
Dysphagia and feeding tube indicate significant functional ... | # Prognostic Assessment for Mrs. Nguyen
Mrs. Nguyen presents a complex case with multiple factors influencing her prognosis following treatment for locally advanced oral tongue SCC. Her prognosis is guarded, requiring a nuanced assessment considering her disease status, comorbidities, functional status, and social con... | prognostic |
Mr. Elias Thorne is a 93-year-old male admitted to the pediatric oncology unit (due to a unique clinical trial inclusion criteria – see below) with relapsed B-cell acute lymphoblastic leukemia (B-ALL). He initially presented 18 months ago with a de novo diagnosis, achieving remission after intensive chemotherapy. He ha... | B-ALL relapse post-TKI: unfavorable prognostic indicator.
Advanced age (>90) significantly worsens outcomes.
High-risk cytogenetics (Ph+) impacts remission duration.
Low KPS (30) indicates limited physiological reserve.
Severe COPD complicates treatment tolerance.
Uncontrolled diabetes increases infection risk.
Osteopo... | # Prognostic Assessment for Mr. Elias Thorne
**Short-Term Prognosis (Days to Weeks):**
Mr. Thorne’s short-term prognosis is guarded. The acute leukemia relapse, coupled with his significant comorbidities, places him at high risk for rapid disease progression, infection (pneumonia is particularly concerning given his C... | prognostic |
A 16-year-old female, Sarah, presents with a confirmed diagnosis of Cystic Fibrosis (CF) – DeltaF508 homozygous mutation. Diagnosed at age 8 after recurrent pneumonia. Current FEV1 is 55% predicted. She experiences frequent pulmonary exacerbations (average 3 per year requiring IV antibiotics). Recent sputum culture gre... | CF severity: Moderate, declining lung function, multi-drug resistance.
Genetic mutation: DeltaF508 – generally associated with worse prognosis.
CFRD presence: Accelerates lung disease, impacts nutritional status.
Chronic *Pseudomonas* & *Burkholderia*: Aggressive infection, poor outcomes.
Nutritional status: Underweigh... | # Prognostic Assessment for Sarah – Cystic Fibrosis
**Short-Term Prognosis (Days to Weeks):**
Sarah is at high risk for an acute pulmonary exacerbation requiring hospitalization within the next few weeks, given her recent sputum cultures, declining FEV1, and history of frequent exacerbations. Her anxiety and potential... | prognostic |
A 28-year-old Vietnamese-American female presents with a 6-month history of progressive nasal obstruction, epistaxis, and left facial swelling. Initial evaluation revealed a locally advanced, high-grade squamous cell carcinoma (SCC) of the left maxillary sinus (T4N2M0, Stage III) confirmed by biopsy and imaging (CT and... | Locally advanced SCC, residual disease: poor initial prognosis.
Positive lymph nodes indicate increased metastatic potential.
Diabetes impairs wound healing, increases infection risk.
Family history suggests genetic predisposition, worse outcomes.
Cisplatin polymorphism: reduced chemotherapy effectiveness.
Anxiety/depr... | # Prognostic Assessment for Maxillary Sinus SCC
This 28-year-old female with Stage III maxillary sinus SCC presents a complex prognostic scenario due to multiple interacting risk factors and limited evidence regarding long-term outcomes in this specific patient profile.
**Short-Term Prognosis (Days to Weeks):**
Her ... | prognostic |
A 9-month-old female infant, born at 32 weeks gestation (birth weight 1.6kg), presents with worsening respiratory distress. She was diagnosed with Bronchopulmonary Dysplasia (BPD) at 3 months, requiring ongoing oxygen support. She has a complex medical history including severe Gastroesophageal Reflux Disease (GERD) req... | BPD severity: moderate-severe, chronic respiratory compromise.
DiGeorge Syndrome: significant immune and cardiac impacts.
GERD post-fundoplication: potential for ongoing complications.
RSV infection: acute exacerbation of respiratory distress.
Growth failure: reflects chronic illness and malnutrition.
PAH: worsens resp... | # Prognostic Assessment for a 9-Month-Old with BPD, DiGeorge Syndrome, and GERD
This infant presents a highly complex case with multiple interacting conditions significantly impacting her prognosis. Accurate prediction is challenging due to limited data specifically addressing this combination of factors.
**Short-Ter... | prognostic |
A 28-year-old female, Ms. Anya Sharma, presents with a confirmed diagnosis of high-risk Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer (NMIBC), specifically high-grade T1G3. Initial cystoscopy revealed a 3cm papillary tumor in the left lateral wall. TURBT pathology confirmed high-grade u... | High-grade, T1G3, BCG-unresponsive: poor initial prognosis.
Persistent CIS indicates aggressive disease biology.
Crohn’s impacts surgical risk and immune response.
Smoking worsens bladder cancer progression risk.
Anxiety affects adherence and quality of life.
ECOG 1: relatively good functional status initially.
PD-L1 p... | # Prognostic Assessment for Ms. Anya Sharma
Ms. Sharma presents a challenging case of BCG-unresponsive, high-risk NMIBC. Her prognosis is significantly impacted by multiple factors, necessitating a nuanced assessment.
**Short-Term Prognosis (Days to Weeks):**
Ms. Sharma is at immediate risk of disease progression des... | prognostic |
Mr. Arthur Penhaligon is a 72-year-old male with a history of Type 2 Diabetes Mellitus (diagnosed 15 years ago, poorly controlled - HbA1c 9.2%), Hypertension (diagnosed 20 years ago, currently managed with amlodipine 10mg daily), and Coronary Artery Disease (status post-stent placement to LAD 5 years ago). He presents ... | Advanced CKD stage, rapidly declining renal function.
Poor diabetes control accelerates kidney disease progression.
High UACR indicates significant glomerular damage.
Cardiovascular disease increases risk of adverse events.
Anemia contributes to fatigue and functional decline.
Hyperkalemia poses immediate cardiac risk.... | # Prognostic Assessment for Mr. Arthur Penhaligon
**Established Diagnosis:** Stage 3b Chronic Kidney Disease secondary to Diabetic Nephropathy with significant comorbidities.
**Short-Term Prognosis (Days to Weeks):** Mr. Penhaligon is at immediate risk of hyperkalemia-induced cardiac arrhythmia. He also faces a high ... | prognostic |
An 8-year-old male of mixed African and European ancestry presents with relapsed B-cell Acute Lymphoblastic Leukemia (B-ALL). He was initially diagnosed 2 years ago with standard-risk B-ALL and completed frontline therapy (ALL-BFM protocol) achieving morphological remission. He relapsed 6 months ago in the bone marrow,... | Relapsed B-ALL indicates poorer overall survival potential.
KMT2A rearrangement: high-risk genetic abnormality present.
MRD positivity post-salvage: unfavorable prognostic indicator.
Age 8: generally better prognosis than older children.
Asthma: potential complication during intensive therapy.
Sickle trait: increased r... | # Prognostic Assessment for Relapsed B-ALL
This 8-year-old patient with relapsed B-ALL presents a complex prognostic scenario. His initial standard-risk diagnosis is overshadowed by multiple adverse features, necessitating a cautious outlook.
**Short-Term Prognosis (Days to Weeks):**
High risk of infection due to ong... | prognostic |
An 8-year-old female presents to the ED with worsening shortness of breath and cough, diagnosed 6 months ago with Stage III B-cell Acute Lymphoblastic Leukemia (ALL), currently in second remission after initial induction and consolidation chemotherapy. She completed maintenance chemotherapy 2 months ago. Her current sy... | ALL remission status: crucial for immediate risk assessment.
Neutropenia significantly increases infection risk and severity.
Asthma complicates respiratory assessment and management.
Rhinovirus infection: common, but severe in immunocompromised.
Psychosocial factors impact adherence and recovery.
Bilateral infiltrates... | # Prognostic Assessment: Relapsed/Refractory ALL with Respiratory Compromise
**Short-Term Prognosis (Days to Weeks):**
Guarded. The patient is at high risk for rapid clinical deterioration due to pneumonia in the setting of profound neutropenia and underlying ALL. Respiratory failure requiring mechanical ventilation i... | prognostic |
Mrs. Eleanor Vance is a 72-year-old Caucasian female presenting for a psychiatric review. She has a well-established diagnosis of Vascular Dementia (VaD), confirmed by neuroimaging (MRI showing multi-infarct dementia) and neuropsychological testing 3 years ago. Her Mini-Mental State Examination (MMSE) score has decline... | VaD severity: MMSE 18 suggests moderate dementia.
Vascular risk factors: Hypertension and atrial fibrillation present.
Comorbid depression: Mild depression impacts cognitive function.
Functional decline: Increasing ADL dependence indicates progression.
Social isolation: Rural location, limited family support problemati... | # Prognostic Assessment for Mrs. Eleanor Vance
**Short-Term Prognosis (Days to Weeks):**
Mrs. Vance is at moderate risk of further functional decline and falls in the immediate future. Her current MMSE score and modified Rankin Scale suggest she requires increasing assistance with activities of daily living. The risk ... | prognostic |
Mr. David Chen, a 48-year-old African American male, presents with Stage III Non-Small Cell Lung Cancer (NSCLC), adenocarcinoma histology, diagnosed 6 months ago. He initially presented with a cough and shortness of breath. Imaging revealed a 7cm primary tumor in the right upper lobe with N2 nodal involvement (ipsilate... | Stage III NSCLC indicates aggressive disease course.
Disease progression post-chemotherapy is concerning.
EGFR mutation suggests targeted therapy potential.
Smoking history increases recurrence and mortality risk.
Diabetes impairs immune function, treatment tolerance.
CKD limits chemotherapy options, increases toxicity... | # Prognostic Assessment for Mr. David Chen
**Short-Term Prognosis (Days to Weeks):**
Mr. Chen’s short-term prognosis is guarded, primarily due to disease progression despite initial chemotherapy response. He is at risk for symptom exacerbation (cough, dyspnea) requiring palliative care interventions. The immediate foc... | prognostic |
Mr. David Miller is a 28-year-old male diagnosed 6 months ago with Crohn's Disease, ileocolonic involvement, confirmed by colonoscopy and pathology (granulomatous inflammation, transmural disease). Initial treatment with oral prednisone was effective, but symptoms recurred upon taper. He is now on infliximab 5mg/kg eve... | Crohn’s: ileocolonic, active inflammation, partial infliximab response.
Young age generally favors better long-term outcomes.
Smoking significantly worsens disease course and treatment response.
Comorbid anxiety impacts adherence and perceived quality of life.
Low albumin suggests ongoing inflammation and malnutrition ... | # Prognostic Assessment for Mr. David Miller – Crohn’s Disease
**Short-Term Prognosis (Days to Weeks):**
Mr. Miller is at moderate risk for another flare within the next few weeks. His persistent symptoms (abdominal pain, frequent bowel movements), elevated inflammatory markers (CRP, ESR), and history of recent predni... | prognostic |
A 9-year-old female of mixed African-American and Caucasian ancestry presents with a known diagnosis of Stage IV High-Risk Medulloblastoma, confirmed by biopsy and MRI. Initial diagnosis was 6 months ago. She completed standard therapy (myeloablative chemotherapy with autologous stem cell rescue, followed by craniospin... | Stage IV medulloblastoma indicates aggressive disease course.
MYC amplification signifies poorer prognosis, rapid progression.
1p/19q LOH correlates with worse overall survival.
Leptomeningeal disease indicates limited treatment options.
Sickle cell trait may complicate high-dose chemotherapy.
ECOG 2 suggests declining... | # Prognostic Assessment: Stage IV High-Risk Medulloblastoma
**Short-Term Prognosis (Days to Weeks):** The patient's short-term prognosis is guarded. Progressive disease with leptomeningeal involvement suggests a rapidly deteriorating neurological status. Without immediate intervention, she is at high risk for increase... | prognostic |
Mr. Jian Li, a 28-year-old Chinese-American male, presents for rheumatology follow-up. He was diagnosed 3 years ago with Ankylosing Spondylitis (AS) based on modified New York criteria, confirmed by positive HLA-B27 and sacroiliitis on MRI. Initially, disease activity was mild, managed with NSAIDs and physical therapy.... | AS severity: persistent inflammation despite TNF inhibitor failure.
HLA-B27 positive, strong family history: genetic predisposition.
Comorbid Crohn’s: potential for overlapping inflammatory pathways.
Uveitis: increased risk of spinal fusion and blindness.
Apical fibrosis: suggests long-term disease impact.
IL23R varian... | # Prognostic Assessment for Mr. Jian Li – Ankylosing Spondylitis
**Short-Term Prognosis (Days to Weeks):**
Mr. Li is at high risk for continued inflammatory back pain and potential uveitis flares. Despite adalimumab, his BASDAI remains elevated, indicating inadequate disease control. He requires immediate attention to... | prognostic |
Mr. Hiroshi Tanaka is an 82-year-old Japanese-American male presenting with worsening symptoms of Child-Pugh C cirrhosis secondary to non-alcoholic steatohepatitis (NASH). He was diagnosed with NASH cirrhosis 5 years ago, initially compensated. He now presents with increasing ascites refractory to diuretic therapy, rec... | Cirrhosis severity: Child-Pugh C, high MELD score indicates advanced disease.
Ascites refractoriness suggests poor liver synthetic function.
Recurrent encephalopathy indicates significant portal-systemic shunting.
Variceal bleeding: high risk of re-bleeding and complications.
Diabetes complicates management and increas... | # Prognostic Assessment for Mr. Hiroshi Tanaka
Mr. Tanaka presents a complex case of advanced cirrhosis with multiple comorbidities and psychosocial challenges, significantly impacting his prognosis. His MELD-Na score of 22 places him in a high-risk category for short-term mortality.
**Short-Term Prognosis (Days to W... | prognostic |
A 6-month-old female infant of Ashkenazi Jewish descent presents with progressively worsening failure to thrive, chronic diarrhea (watery, non-bloody, 8-10 stools/day), and recurrent respiratory infections. She was diagnosed with Cystic Fibrosis (CF) at 2 months old following a positive newborn screen (deltaF508 homozy... | CFTR mutation type impacts disease severity.
Early *Pseudomonas* colonization worsens prognosis.
Meconium ileus indicates severe pancreatic insufficiency.
Nutritional deficits impair growth and immune function.
CFRD accelerates lung disease progression.
Declining FEV1 signifies worsening respiratory function.
Maternal ... | # Prognostic Assessment for a 6-Month-Old with Cystic Fibrosis
This 6-month-old female with Cystic Fibrosis presents a complex case with multiple high-risk factors, necessitating a detailed prognostic assessment. Her prognosis is significantly guarded.
**Short-Term Prognosis (Days to Weeks):**
Her immediate prognosis... | prognostic |
A 48-year-old African American female with a 15-year history of Type 1 Diabetes Mellitus (T1DM), poorly controlled (HbA1c consistently 9.5-11%), presents with newly diagnosed primary hyperparathyroidism (PHPTH) confirmed by elevated serum calcium (11.8 mg/dL, normal 8.5-10.5), PTH (180 pg/mL, normal 10-65), and 24-hour... | T1DM duration and control significantly impact prognosis.
PHPTH severity: hypercalcemia, PTH levels are substantial.
CKD stage 3 accelerates cardiovascular risk and mortality.
Osteoporosis increases fracture risk, impacting function.
Genetic predisposition (MEN2A) suggests future risks.
Poor social support worsens dise... | # Prognostic Assessment for a 48-Year-Old Female with T1DM and PHPTH
This patient presents a complex case with multiple interacting conditions requiring a nuanced prognostic assessment. Her prognosis is significantly impacted by the interplay of poorly controlled T1DM, PHPTH, CKD, osteoporosis, genetic predisposition,... | prognostic |
A 9-month-old female infant of Ashkenazi Jewish descent presents with progressively worsening hypotonia, failure to thrive, and developmental delay noted since 6 months of age. She was born at 38 weeks gestation via uncomplicated vaginal delivery. Initial newborn screening was normal. Family history is significant for ... | Tay-Sachs: infantile form, severe neurological deterioration.
Genetic mutations confirm diagnosis, poor prognosis.
Hypotonia and atrophy indicate rapid disease progression.
Respiratory failure necessitates ongoing support.
Failure to thrive worsens overall functional status.
Elevated CK suggests muscle involvement, acc... | # Prognostic Assessment: Infantile Tay-Sachs Disease
This 9-month-old infant with genetically confirmed infantile Tay-Sachs disease faces a profoundly challenging prognosis. The disease is characterized by progressive neurodegeneration due to the deficiency of beta-hexosididase A, leading to accumulation of GM2 gangli... | prognostic |
Eleven-year-old female, Maya, presents with a confirmed diagnosis of Juvenile Idiopathic Arthritis (JIA), systemic onset, established 6 months ago. Initial presentation included high spiking fevers, evanescent rash, and arthritis affecting multiple joints (wrists, knees, ankles). Currently on methotrexate 15mg/m²/week ... | Systemic JIA indicates potentially aggressive disease course.
Elevated DAS28 signifies inadequate disease control.
Uveitis represents serious, vision-threatening complication.
Asthma adds comorbidity, potential treatment interactions.
Methotrexate response suboptimal; escalation needed.
Psychosocial stress impacts adhe... | # Prognostic Assessment for Maya – Systemic JIA
**Short-Term Prognosis (Days to Weeks):**
Maya is at moderate risk for continued disease flares and uveitis exacerbation if current treatment remains unchanged. Pain control will likely remain suboptimal. There is a risk of medication side effects from methotrexate and s... | prognostic |
Mr. Arthur Penhaligon is an 82-year-old male presenting with worsening dysphagia and hoarseness. He was diagnosed six months ago with locally advanced squamous cell carcinoma (SCC) of the supraglottis (Stage III, T3N1M0) confirmed by biopsy and PET/CT. He completed definitive chemoradiation therapy (cisplatin-based) th... | SCC recurrence post-chemoradiation indicates aggressive biology.
Local recurrence suggests treatment failure or resistance.
Age 82 increases risk of treatment complications.
Comorbidities (heart/kidney/diabetes) limit treatment options.
Weight loss signifies disease progression and poor reserve.
ECOG 1 suggests moderat... | # Prognostic Assessment for Mr. Arthur Penhaligon
**Short-Term Prognosis (Days to Weeks):**
Mr. Penhaligon faces a guarded short-term prognosis. The primary concern is worsening dysphagia leading to aspiration pneumonia and malnutrition. His functional status, while currently moderate, is likely to decline rapidly wit... | prognostic |
Ethan, a 9-year-old male, is diagnosed with severe eosinophilic esophagitis (EoE) complicated by food protein-induced enterocolitis syndrome (FPIES) to milk and soy. He presented initially with dysphagia, vomiting, and failure to thrive. Endoscopy revealed esophageal rings and eosinophilic infiltration (peak 35 eosinop... | EoE severity: High eosinophil count, dysphagia, failure to thrive.
FPIES adds complexity, potential for severe reactions.
Recurrent pneumonia indicates aspiration risk, immune compromise.
Poorly controlled asthma worsens respiratory morbidity.
Low BMI signifies nutritional deficiency, growth impairment.
Autoimmune fami... | # Prognostic Assessment for Ethan – Severe EoE & FPIES
**Short-Term Prognosis (Days to Weeks):**
Ethan faces a high risk of acute exacerbations of EoE symptoms (dysphagia, vomiting) and potential FPIES reactions if accidental ingestion occurs. His risk of aspiration pneumonia remains elevated. Nutritional status is pr... | prognostic |
Ms. Anya Sharma is a 52-year-old Filipina woman with a 7-year history of Parkinson’s Disease (PD), initially presenting with right-sided tremor and mild rigidity. Her diagnosis was confirmed with DaTscan imaging. She currently presents with Hoehn & Yahr stage 3 PD, experiencing significant bradykinesia, rigidity affect... | PD stage 3 indicates moderate disease severity.
LRRK2 mutation suggests potentially faster progression.
RBD strongly correlates with future dementia risk.
Frequent falls increase morbidity and mortality risk.
MND complicates management and worsens prognosis.
Hypertension, if uncontrolled, worsens vascular risk.
Strong ... | # Prognostic Assessment for Ms. Anya Sharma
Ms. Sharma presents a complex case of Parkinson’s Disease with several factors influencing her prognosis. Her age of onset (45) and the presence of the LRRK2 G2019S mutation suggest a potentially more aggressive disease course compared to sporadic PD. The co-occurrence of RB... | prognostic |
Mr. David Chen, a 28-year-old Vietnamese-American male, presents with a confirmed diagnosis of Systemic Lupus Erythematosus (SLE) diagnosed 3 years ago. Initial presentation involved polyarthritis, malar rash, and serositis. He currently presents with worsening proteinuria (4.5g/day), rising creatinine from 0.8mg/dL to... | SLE severity: Active nephritis, hypertension, proteinuria significant.
Renal involvement: Progressive decline in renal function concerning.
Prior immunosuppression: Cyclophosphamide increases long-term risks.
Comorbidities: Hypertension and cardiovascular risk elevate risk.
APOL1 genotype: High-risk variant suggests fa... | # Prognostic Assessment for Mr. David Chen – SLE with Lupus Nephritis
**Short-Term Prognosis (Days to Weeks):**
Mr. Chen is at moderate risk for acute kidney injury progression and cardiovascular events in the immediate future. His uncontrolled hypertension and active nephritis necessitate prompt intervention. Expect ... | prognostic |
Mr. Hiroshi Tanaka is an 82-year-old Japanese-American male with a 15-year history of Type 2 Diabetes Mellitus, poorly controlled (HbA1c consistently 8.5-9.5%). He presented 3 weeks ago with progressive fatigue, lower extremity edema, and shortness of breath. Initial workup revealed a serum creatinine of 3.2 mg/dL (bas... | Stage 4 CKD significantly impacts overall prognosis.
Poor diabetes control accelerates nephropathy progression.
Cardiovascular disease increases mortality risk.
Atrial fibrillation raises stroke and heart failure risk.
Recent fracture impairs function, increases complications.
Limited social support hinders self-manage... | # Prognostic Assessment for Mr. Hiroshi Tanaka
Mr. Tanaka presents a complex case with multiple interacting conditions significantly impacting his prognosis. His advanced CKD, poorly controlled diabetes, cardiovascular disease, recent fracture, and limited social support create a high-risk profile.
**Short-Term Progn... | prognostic |
Mr. Arthur Penhaligon is an 82-year-old male with a history of longstanding, poorly controlled Type 2 Diabetes Mellitus (diagnosed 20 years ago, HbA1c consistently >8.5%), hypertension (managed with three agents), hyperlipidemia (LDL consistently >100 despite statin therapy), and chronic kidney disease (CKD stage 3b, e... | Acute limb ischemia: severe, threatens limb viability.
Diabetes: poor control, accelerates atherosclerosis, impairs healing.
CKD: increases cardiovascular risk, limits revascularization options.
Atrial fibrillation: stroke risk, impacts treatment decisions.
Prior MI: increased risk of further cardiac events.
Functional... | # Prognostic Assessment for Mr. Arthur Penhaligon
Mr. Penhaligon presents a complex case with multiple interacting comorbidities significantly impacting his prognosis. His acute limb ischemia, superimposed on a background of severe cardiovascular disease and renal insufficiency, necessitates a careful and nuanced asse... | prognostic |
A 28-year-old female, Ms. Anya Sharma, presents for follow-up 6 months after diagnosis of Systemic Lupus Erythematosus (SLE). Diagnosis was based on meeting 4/11 ACR criteria (malar rash, serositis, hematologic abnormalities - lymphopenia, and positive ANA with anti-dsDNA antibodies). Initial presentation included sign... | SLE severity: moderate, persistent activity, nephritis progression.
Renal involvement: increasing proteinuria, potential disease flare.
Psychosocial factors: anxiety, depression, financial stress impact.
Adherence issues: nausea, inconsistent medication taking.
Cardiovascular risk: family history, potential medication ... | # Prognostic Assessment for Ms. Anya Sharma
**Short-Term Prognosis (Days to Weeks):**
Ms. Sharma is at risk for a near-term lupus flare requiring hospitalization if medication adherence doesn’t improve and proteinuria continues to rise. Her anxiety and depression could worsen, potentially leading to suicidal ideation.... | prognostic |
A 28-year-old African American female presents with a confirmed diagnosis of Systemic Lupus Erythematosus (SLE) established 3 years prior. Initial presentation included malar rash, serositis, and arthritis. Currently, she presents with worsening proteinuria (4.5g/day), elevated creatinine (1.8mg/dL, baseline 0.8mg/dL),... | SLE severity: High SLEDAI, renal, neurological involvement.
Renal disease: Proteinuria, creatinine elevation, poor prognosis.
Neurological involvement: Seizures, cognitive dysfunction, significant risk.
C3/C4 deficiency: Increased susceptibility to infection, flares.
aPL syndrome: Thrombotic risk, refractory disease.
P... | # Prognostic Assessment for Systemic Lupus Erythematosus
This 28-year-old African American female with SLE presents a complex case with multiple high-risk features, significantly impacting her prognosis. Her disease is severe, refractory, and complicated by genetic predisposition, immunodeficiency, and psychosocial fa... | prognostic |
Mr. Hiroshi Tanaka is an 82-year-old Japanese-American male presenting with worsening symptoms of late-onset schizophrenia, diagnosed 3 years prior at age 79. He lives alone in a rural area with limited public transportation. His initial presentation involved persecutory delusions and auditory hallucinations, respondin... | Late-onset schizophrenia generally has poorer prognosis.
Negative symptoms predict worse functional outcomes.
Cognitive impairment exacerbates functional decline.
Comorbid diabetes impacts overall health and recovery.
Social isolation increases risk of deterioration.
*APOE4* allele linked to increased psychosis risk.
T... | # Prognostic Assessment for Mr. Hiroshi Tanaka
Mr. Tanaka presents a complex case with multiple factors influencing his prognosis. His late-onset schizophrenia, coupled with treatment resistance, cognitive impairment, and social isolation, paints a concerning picture. The presence of comorbid medical conditions (hyper... | prognostic |
A 6-month-old male infant presents with bilateral Retinopathy of Prematurity (ROP), stage 3, zone 1, plus disease in both eyes, diagnosed 2 weeks prior. He was born at 26 weeks gestation, birth weight 850g. He required prolonged mechanical ventilation (6 weeks) for respiratory distress syndrome and developed a grade 2 ... | ROP stage/zone indicates aggressive disease, poor prognosis.
Prematurity significantly elevates ROP progression risk.
Intraventricular hemorrhage impacts neurodevelopmental outcomes.
Chronic lung disease complicates systemic management.
Poor weight gain suggests nutritional deficiencies, impacting healing.
*NDNF* mutat... | # Prognostic Assessment: Bilateral ROP Stage 3, Zone 1, Plus Disease
This 6-month-old infant with ROP presents a complex case with multiple factors influencing prognosis. The combination of severe ROP, prematurity, comorbidities, and psychosocial challenges necessitates a detailed assessment.
**Short-Term Prognosis (... | prognostic |
A 7-day-old female infant, born at 32 weeks gestation (birth weight 1.6kg), presents with worsening abdominal distension, bilious emesis, and failure to pass meconium. Prenatal ultrasound suggested possible intestinal malrotation. Postnatal course complicated by respiratory distress syndrome requiring 5 days of mechani... | Prematurity increases risk of complications, poor outcomes.
Malrotation/Volvulus: surgical emergency, immediate intervention needed.
Respiratory distress syndrome impacts overall physiological reserve.
TPN associated risks: infection, liver dysfunction, thrombosis.
CFTR mutation: potential for future CF-related issues.... | # Prognostic Assessment: Neonatal Intestinal Malrotation with Comorbidities
This 7-day-old female infant presents a complex case of neonatal intestinal malrotation with a suspected volvulus, complicated by prematurity, respiratory distress syndrome, a VSD, and a heterozygous CFTR mutation. Prognostic assessment requir... | prognostic |
A 28-year-old African American female presents with a known diagnosis of Systemic Lupus Erythematosus (SLE) established 5 years prior. She initially presented with serositis and arthritis, managed with hydroxychloroquine. Over the past year, she experienced increasing disease activity despite escalating immunosuppressi... | SLE severity: active, multi-organ involvement, refractory to treatment.
ILD pattern: UIP suggests poorer prognosis than non-UIP patterns.
PFTs: restrictive pattern indicates significant lung function impairment.
Comorbid hypertension: increases cardiovascular risk, impacts prognosis.
Depression: affects adherence, qual... | # Prognostic Assessment for SLE-ILD
This 28-year-old African American female with SLE-ILD presents a complex prognostic challenge due to multiple interacting factors. Her disease is severe, refractory to conventional treatment, and complicated by significant lung involvement, comorbidities, and psychosocial stressors.... | prognostic |
A 16-year-old female, Sarah, presents to the PICU following a motor vehicle collision. She sustained a traumatic brain injury (TBI) – diffuse axonal injury (DAI) – classified as severe based on GCS of 6 initially, now 8 after initial resuscitation. She also has a left femur fracture and a splenic rupture requiring emer... | Severe TBI impacts neurological recovery potential.
DAI prognosis is notoriously difficult to predict.
Splenectomy increases infection risk significantly.
CF exacerbates pulmonary vulnerability post-trauma.
Pre-injury functional status: excellent, positive factor.
Social support limited, hindering rehabilitation access... | # Prognostic Assessment for Sarah – Severe Traumatic Brain Injury with Comorbidities
**Short-Term Prognosis (Days to Weeks):**
Sarah’s short-term prognosis is guarded. The primary concern is neurological recovery from the severe DAI. She remains at high risk for secondary brain injury (cerebral edema, ischemia). Pul... | prognostic |
A 7-day-old female infant, born at 28 weeks gestation (birth weight 850g), initially presented with respiratory distress syndrome requiring surfactant administration and mechanical ventilation. She was diagnosed with early-onset Group B Streptococcus (GBS) sepsis confirmed by positive blood culture. She completed a 10-... | Prematurity significantly increases sepsis vulnerability and mortality.
CRKP infection indicates antimicrobial resistance, worsening prognosis.
IVH grade III predicts neurodevelopmental impairment risk.
Persistent hypotension signifies severe sepsis and organ dysfunction.
AKI indicates renal impairment, complicating ma... | # Prognostic Assessment: Late-Onset CRKP Sepsis in a VLBW Infant
This case presents a critically ill newborn with a complex constellation of factors impacting prognosis. The combination of extreme prematurity, multi-drug resistant infection, intraventricular hemorrhage, and significant comorbidities creates a high-ris... | prognostic |
Mr. Elias Vance is a 72-year-old African American male with a history of Child-Pugh B cirrhosis secondary to chronic Hepatitis C (genotype 1a) and alcohol use disorder (currently abstinent for 6 months). He presented 3 days ago with acute decompensation manifesting as worsening ascites, hepatic encephalopathy (grade 2,... | Cirrhosis severity: Child-Pugh B, MELD-Na 22 – significant disease.
Acute SBP complicates prognosis, increases short-term mortality.
Hepatitis C genotype 1a: less responsive to direct-acting antivirals.
Diabetes and CKD worsen liver disease progression, outcomes.
PNPLA3 polymorphism: increased fibrosis, poorer treatmen... | # Prognostic Assessment for Mr. Elias Vance
Mr. Vance presents a complex case of decompensated cirrhosis with multiple high-risk factors, necessitating a detailed prognostic assessment.
**Short-Term Prognosis (Days to Weeks):**
His immediate prognosis is guarded due to recent SBP and ongoing hepatic encephalopathy. D... | prognostic |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.